David R. Mottram

2.4k total citations · 1 hit paper
84 papers, 1.8k citations indexed

About

David R. Mottram is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Geriatrics and Gerontology. According to data from OpenAlex, David R. Mottram has authored 84 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 20 papers in Cellular and Molecular Neuroscience and 19 papers in Geriatrics and Gerontology. Recurrent topics in David R. Mottram's work include Pharmaceutical Practices and Patient Outcomes (19 papers), Receptor Mechanisms and Signaling (15 papers) and Pharmacovigilance and Adverse Drug Reactions (14 papers). David R. Mottram is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (19 papers), Receptor Mechanisms and Signaling (15 papers) and Pharmacovigilance and Adverse Drug Reactions (14 papers). David R. Mottram collaborates with scholars based in United Kingdom, United States and Egypt. David R. Mottram's co-authors include Munir Pirmohamed, Christopher F. Green, Emma Davies, Stephen Taylor, Paula Williamson, Philip Rowe, P.H. Rowe, Mark Stuart, J. D. Lever and Neil Chester and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and Sports Medicine.

In The Last Decade

David R. Mottram

81 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

2009 525 citations Emma Davies, Christopher F. Green et al. profile →

Peers

David R. Mottram

TOXIC

PPCH

PHARM

Tom Mjörndal Sweden

Philip A. Routledge United Kingdom

Haleh Bagheri France

Anna K. Jönsson Sweden

Andrew Scott United Kingdom

Jerry L. Bauman United States

Corinne M. Hohl Canada

Janet Sultana Italy

L. F. Gram Denmark

Odd Brørs Norway

Tom Mjörndal Sweden

David R. Mottram

423 ×0.6

TOXIC

258 ×0.4

325 ×0.7

PPCH

149 ×0.6

236 ×1.1

PHARM

Citations per year, relative to David R. Mottram David R. Mottram (= 1×) peers Tom Mjörndal

Countries citing papers authored by David R. Mottram

Since Specialization

Citations

This map shows the geographic impact of David R. Mottram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David R. Mottram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David R. Mottram more than expected).

Fields of papers citing papers by David R. Mottram

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David R. Mottram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David R. Mottram. The network helps show where David R. Mottram may publish in the future.

Co-authorship network of co-authors of David R. Mottram

This figure shows the co-authorship network connecting the top 25 collaborators of David R. Mottram. A scholar is included among the top collaborators of David R. Mottram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David R. Mottram. David R. Mottram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stuart, Mark & David R. Mottram. (2018). New IOC Certificate in Drugs in Sport supports healthcare professionals to lead on effective clinical drug use and doping prevention in athletes. British Journal of Sports Medicine. 53(1). 48–49. 5 indexed citations

Mottram, David R., et al.. (2016). Perspective of pharmacists in Qatar regarding doping and anti-doping in sports.. PubMed. 56(6). 817–24. 12 indexed citations

Sison‐Young, Rowena, Rosalind E. Jenkins, David R. Mottram, et al.. (2015). Comparative Proteomic Characterization of 4 Human Liver-Derived Single Cell Culture Models Reveals Significant Variation in the Capacity for Drug Disposition, Bioactivation, and Detoxication. Toxicological Sciences. 147(2). 412–424. 72 indexed citations

Davies, Emma, Christopher F. Green, David R. Mottram, Philip Rowe, & Munir Pirmohamed. (2010). Emergency re‐admissions to hospital due to adverse drug reactions within 1 year of the index admission. British Journal of Clinical Pharmacology. 70(5). 749–755. 87 indexed citations

Mottram, David R., et al.. (2008). Athletes' Knowledge and Views on OTC Medication. International Journal of Sports Medicine. 29(10). 851–855. 28 indexed citations

Davies, Emma, et al.. (2008). The use of opioids and laxatives, and incidence of constipation, in patients requiring neck-of-femur (NOF) surgery: a pilot study. Journal of Clinical Pharmacy and Therapeutics. 33(5). 561–566. 30 indexed citations

Davies, Emma, et al.. (2006). Adverse drug reactions in hospital in-patients: a pilot study. Journal of Clinical Pharmacy and Therapeutics. 31(4). 335–341. 67 indexed citations

Mottram, David R.. (2005). DRUGS IN SPORT. Journal of Sports Science and Medicine. 4(4). 620. 8 indexed citations

Mottram, David R., et al.. (2003). Over-the-counter drug use amongst athletes and non-athletes.. PubMed. 43(1). 111–8. 15 indexed citations

10.

Reilly, T., et al.. (2003). Physiological, Subjective and Performance Effects of Pseudoephedrine and Phenylpropanolamine During Endurance Running Exercise. International Journal of Sports Medicine. 24(1). 3–8. 22 indexed citations

11.

Chester, Neil, David R. Mottram, Thomas Reilly, & Mark L. Powell. (2003). Elimination of ephedrines in urine following multiple dosing: the consequences for athletes, in relation to doping control. British Journal of Clinical Pharmacology. 57(1). 62–67. 20 indexed citations

12.

Green, Christopher F., David R. Mottram, Philip Rowe, & Munir Pirmohamed. (2001). Attitudes and knowledge of hospital pharmacists to adverse drug reaction reporting. British Journal of Clinical Pharmacology. 51(1). 81–86. 150 indexed citations

13.

Mottram, David R., et al.. (2000). Anabolic steroids. Best Practice & Research Clinical Endocrinology & Metabolism. 14(1). 55–69. 78 indexed citations

14.

Mottram, David R., et al.. (2000). Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. Journal of Clinical Pharmacy and Therapeutics. 25(5). 355–361. 54 indexed citations

15.

Mottram, David R., et al.. (1999). Communication regarding adverse drug reactions between secondary and primary care: a postal questionnaire survey of general practitioners. Journal of Clinical Pharmacy and Therapeutics. 24(2). 133–139. 14 indexed citations

16.

Dearden, John C., et al.. (1998). QSAR Study of the α1‐Adrenoceptor Antagonist Activity of WB4101 Derivatives. Pharmacy and Pharmacology Communications. 4(2). 89–93. 2 indexed citations

17.

Mottram, David R., et al.. (1997). Comparative evaluation of patient information leaflets by pharmacists, doctors and the general public. Journal of Clinical Pharmacy and Therapeutics. 22(2). 127–134. 44 indexed citations

18.

Thornton, Everard W., et al.. (1990). Intra-habenular injection of 6-hydroxydopamine produces impaired acquisition of DRL operant behavior. Behavioral and Neural Biology. 53(2). 291–297. 11 indexed citations

19.

Mottram, David R., et al.. (1988). Drugs in Sport. 3 indexed citations

20.

Mottram, David R., et al.. (1973). Studies on the acetylcholinesterase (ache)-positive and -negative autonomic axons supplying smooth muscle in the normal and 6-hydroxydopamine (6-OHDA)treated rat iris. Cell and Tissue Research. 138(2). 211–222. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact